Endiya Partners, a leading early-stage venture capital firm, has proudly cemented its position among India’s top-performing seed investors. According to the firm, its debut fund—launched in 2016 with a corpus of ₹175 crore—has delivered an impressive 4x return on invested capital, securing Endiya a spot among the best-performing funds of its vintage.
The fund’s disciplined investment strategy has paid off handsomely, with several notable exits and a robust IPO pipeline. Endiya’s focus areas span SaaS, cybersecurity, semiconductors, and digital health—sectors that continue to dominate India’s growing startup landscape.
Strategic Bets on Future-Ready Startups
Among Endiya’s most successful bets is Darwinbox, the enterprise HR-tech platform that has now grown into a global unicorn. Endiya led the seed funding round for the company, which recently raised $140 million in growth capital from global investors KKR and Partners Group.
Other success stories include Steradian Semiconductors, later acquired by Japanese chipmaker Renesas, and ShieldSquare, which was snapped up by cybersecurity giant Radware.
Sateesh Andra, Managing Director at Endiya Partners, emphasized the fund’s consistent strategy of backing companies built in India for global markets. “Our strength lies in identifying category-defining startups early and supporting them through disciplined investing. This sets us apart in India’s early-stage venture ecosystem,” Andra shared.
Impressive Follow-on Capital and Exit Pathways
Endiya Partners takes pride in the impact its portfolio companies have made. For every $1 invested, its startups have attracted more than $50 in follow-on funding, reflecting the strength of the ventures they back.
“Almost 85% of our portfolio has gone on to raise additional rounds. This reaffirms our commitment to spotting scalable businesses early,” said Ramesh Byrapaneni, Managing Director at Endiya. “Our thesis-driven approach has been critical to Fund I’s performance.”
Endiya’s operator-led model is designed to do more than provide capital. The firm actively supports startups with product rollouts, talent acquisition, business development introductions, and strategic fundraising. This hands-on support strengthens their portfolio’s ability to scale and dominate their respective industries.
Portfolio Growth and Future IPO Pipeline
In the healthcare tech sector, SigTuple—an AI-driven pathology platform—recently signed a global licensing deal with Horiba. Additionally, Endiya is anticipating liquidity events soon, with Kissht’s IPO slated within the next year and CureFit’s public listing also on the horizon.
Riding on Fund I’s success, Endiya’s second fund has built a robust portfolio of high-growth startups such as Scrut Automation, Zluri, EyeStem, Sugarfit, Qapita, Mylo, AquaExchange, and BluJ Aerospace—alongside the unicorn Darwinbox.
Backing the Next Wave of Disruptive Startups
Endiya Partners continues to double down on India’s booming startup ecosystem with its third fund, backed by institutional powerhouses like the International Finance Corporation (IFC) and the Asian Infrastructure Investment Bank (AIIB). This fund has already made strategic investments in four companies operating in enterprise tech, industrial technology, healthcare, and life sciences—namely AltiusHub, Perceptyne, Pulse, and Nivaan Care.
Endiya’s journey showcases how a clear investment thesis, disciplined capital deployment, and hands-on support can create lasting impact. As India’s startup scene continues to flourish, Endiya Partners looks well-positioned to nurture the next wave of global champions.
